These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 33321899)

  • 21. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease.
    da Rocha MD; Viegas FP; Campos HC; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):251-70. PubMed ID: 20874701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinesterase inhibitors for Alzheimer's disease.
    Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD005593. PubMed ID: 16437532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
    Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ameliorative Impact of
    Sahraei R; Aminyavari S; Hosseini M; Hassanzadeh-Taheri M; Foadoddini M; Saebipour MR
    Basic Clin Neurosci; 2022; 13(1):25-34. PubMed ID: 36589020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview.
    Kumar A; Singh A; Aggarwal A
    Indian J Exp Biol; 2017 Feb; 55(2):63-73. PubMed ID: 30183230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholinesterase inhibition in Alzheimer's Disease.
    Ibach B; Haen E
    Curr Pharm Des; 2004; 10(3):231-51. PubMed ID: 14754384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
    Dey A; Bhattacharya R; Mukherjee A; Pandey DK
    Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of five Ayurvedic herbs on locomotor behaviour in a Drosophila melanogaster Parkinson's disease model.
    Jansen RL; Brogan B; Whitworth AJ; Okello EJ
    Phytother Res; 2014 Dec; 28(12):1789-95. PubMed ID: 25091506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials.
    Basheer A; Agarwal A; Mishra B; Gupta A; Padma Srivastava MV; Kirubakaran R; Vishnu V
    Interact J Med Res; 2022 Aug; 11(2):e38542. PubMed ID: 35612544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.
    Tripathi PN; Lodhi A; Rai SN; Nandi NK; Dumoga S; Yadav P; Tiwari AK; Singh SK; El-Shorbagi AA; Chaudhary S
    Degener Neurol Neuromuscul Dis; 2024; 14():47-74. PubMed ID: 38784601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease.
    Iqubal A; Iqubal MK; Fazal SA; Pottoo FH; Haque SE
    Curr Mol Pharmacol; 2022; 15(1):23-50. PubMed ID: 33687906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
    O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
    J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer's Disease.
    Chen SY; Gao Y; Sun JY; Meng XL; Yang D; Fan LH; Xiang L; Wang P
    Front Pharmacol; 2020; 11():497. PubMed ID: 32390843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
    Tuzimski T; Petruczynik A
    Molecules; 2022 May; 27(10):. PubMed ID: 35630702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
    Musiał A; Bajda M; Malawska B
    Curr Med Chem; 2007; 14(25):2654-79. PubMed ID: 17979717
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.